This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
American College of Obstetrics and Gynecology Technical Bulletin: Uterine leiomyomata. Number 192:1–9, May 1994
- Uterine leiomyomata: Etiology, symptomatology, and management.Fertil Steril. 1981; 26: 433-445
- An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double-blind, placebo-controlled, crossover trial.J Clin Endocrinol Metab. 1993; 76: 1217-1223
- Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri.Fertil Steril. 1986; 45: 624-629
- Treatment of large fibroids with high doses of gestrinone.Gynecol Obstet Invest. 1990; 30: 44-47
- Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesterone.Am J Obstet Gynecol. 1986; 155: 761-767
- Long-term treatment of leiomyomas with gestrinone.Fertil Steril. 1989; 51: 939-946
- A medical treatment for myomata uteri.Fertil Steril. 1983; 39: 429-430
- Treatment with GnRH agonists before myomectomy and the a risk short-term myoma recurrence.Br J Obstet Gynaecol. 1990; 97: 393-396
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue.Am J Obstet Gynecol. 1983; 147: 726-727
- Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: A pilot study.Fertil Steril. 1989; 51: 526-528
- Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.Fertil Steril. 1989; 52: 152-154
- Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.Fertil Steril. 1987; 48: 560-564
- A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.Fertil Steril. 1988; 49: 404-409
- Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.Fertil Steril. 1992; 58: 413-415
- A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin “addback” regimens for women with leiomyomata uteri.J Clin Endocrinol Metab. 1993; 76: 1439-1445
- A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.Fertil Steril. 1989; 51: 251-256
- Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study.Obstet Gynecol. 1991; 77: 720-725
- A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.Fertil Steril. 1989; 52: 728-733
- Estimation of nongravid uterine volume based on a nomogram of gravid uterine volume: Its value in gynecologic uterine abnormalities.Obstet Gynecol. 1988; 72: 86-90
- Progesterone therapy in uterine fibromyoma.J Clin Endocrinol. 1946; 6: 402-408
- Toward removing uterine fibroids without surgery: Subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.J Clin Endocrinol Metab. 1986; 63: 619-625
- Uterine leiomyosarcoma with massive necrosis diagnosed during gonadotropin-releasing hormone analog therapy for presumed uterine fibroid.Fertil Steril. 1991; 56: 778-780
- The effect of a gonadotropin-releasing hormone agonist analog (Nafarelin) on bone metabolism.J Clin Endocrinol Metab. 1988; 67: 701-706
- Mitotic activity in uterine leiomyomas during the menstrual cycle.Am J Obstet Gynecol. 1989; 160: 637-641
- Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.Fertil Steril. 1988; 49: 538-541
- Goserelin therapy before surgery for uterine bleeding.Lancet. 1987; 1: 36-37
- Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)—lack of shrinkage of uterine fibroids.Fertil Steril. 1989; 52: 924-929
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot study.Am J Obstet Gynecol. 1985; 152: 1035-1038
- Treatment of peri-menopausal women: Potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy.Br J Obstet Gynaecol. 1992; 99: 13-17
- Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma.Obstet Gynecol. 1988; 158: 361-364
- Primary and myoma-associated menorrhagia: Role of prostaglandins and effects of ibuprofen.Br J Obstet Gynaecol. 1986; 86: 974-978
- Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women.Clin Endocrinol (Oxf). 1988; 29: 45-51
- Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.Fertil Steril. 1988; 49: 1083-1085
- Response of fibromyomas to a progestin.Am J Obstet Gynecol. 1961; 82: 754-759
- Regression of uterine leiomyomata in response to the antiprogesterone RU 486.J Clin Endocrinol Metab. 1993; 76: 513-517
- A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.Obstet Gynecol. 1989; 74: 856-862
- GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.Obstet Gynecol. 1991; 78: 540-541
- Leiomyomas: Steroid receptor content. Variation within normal menstrual cycles.Am J Obstet Gynecol. 1982; 143: 6-11
- A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.Am J Obstet Gynecol. 1991; 164: 1420-1425
- Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.Fertil Steril. 1988; 49: 792-796
- Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.Hum Reprod. 1992; 7: 328-332
- Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): A luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.Fertil Steril. 1987; 48: 45-51
- Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.Obstet Gynecol. 1980; 55: 20-24
Article info
Identification
Copyright
© 1994 Elsevier B.V. Company. Published by Elsevier Inc. Published by Elsevier Inc. All rights reserved.
